资讯

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
Drugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss. Another medication in the same ...
Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
MariTide is designed to combine the effects of glucagon-like peptide-1 (GLP-1) receptor activation with glucose-dependent ...
Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.
In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained ...
The once-monthly drug is still under study but could provide added convenience and another option for patients.
The new weight loss drug which is set to give Ozempic and Mounjaro a run for their money, MariTide, is taken on a monthly ...
Amgen's experimental obesity drug MariTide showed promising weight loss results with fewer side effects, according to a ...
At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP-1 drugs, it targets a hormone that slows stomach emptying. Over 12 weeks, ...
Trial finds weight loss drug taken monthly helps people lose 20% of body weight - The new drug may rival other weight loss ...